| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |